Skip to main content
. 2016 Sep 22;90(12):2979–3003. doi: 10.1007/s00204-016-1845-1

Table 4.

Overview of relevant processes and mechanism involved in DILI of training compounds

Training compound 1 2 3 4 5
Mitotoxicity CRM Lysosomal Biliary Immune
Fialuridine
Acetaminophen ✓ (Innate)
Diclofenac
Amiodarone
Perhexiline
Bosentan
Tolcapone
Nefazodone
Troglitazone
Ximelagatran ✓ (Adaptive)
Flucloxacillin ✓ (Adaptive)